According to “TrialSite News” on January 21, “Apparently, a judge just ordered the Millard Fillmore Suburban Hospital to allow an 80-year old woman to be treated with Ivermectin. A New York Supreme Court judge ordered hospital to allow her to be treated with Ivermectin for COVID-19. Ivermectin, which had been administered in the ICU with […]
Search Results for: COVID
Success in 2020/IDSA Guidelines/Pat Smith Last WG Remarks/Disulfiram/Attempt to Save a Lyme/COVID Patient/Lyme Pathogenesis/COVID
Success in 2020: Help LDA Work for You in the New Year! The Lyme Disease Association, Inc. (LDA) has been working for Lyme and tick-borne diseases (TBD) for 30 years, with individuals who are patients and family members of patients driving the programs. ~97% of our funds generally go directly to programs. Guidestar.org designates LDA as a charity at its highest level committed to transparency, Platinum. For 15 years, LDA has been designated as a national charity included in the Combined Federal Campaign (CFC) lists for federal employees workplace giving.
Peter A. McCullough, M.D., M.P.H., Vice Chief of Internal Medicine, Baylor University Medical Center, et al. published an article in the American Journal of Medicine, August 2020: “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.” The authors have proposed an algorithm based on age and comorbidities that allows for a large proportion to be monitored and treated at home during self-isolation with the aim of reducing the risks of hospitalization and death.
The Lyme Disease Association thanks Congressman Chris Smith and Dr. Richard Horowitz for their valiant efforts to help a chronic Lyme disease patient hospitalized with COVID-19. The following Blog, posted on his Facebook, is reprinted with permission from Dr. Richard Horowitz. The LDA applauds these two courageous individuals trying to buck the system to save a life.
New IDSA Guidelines/Failure to Commandeer Patient Chapter/#GivingTues/New Test for Lyme/CO Ticks/Updated COVID Protocol/Canine-Human Lyme Data/Next WG Meeting/LDA Thanks 51 Groups/DoD: Funds Lyme Vaccine
The Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) announced on November 30, 2020, new guidelines for prevention, diagnosis, and treatment of Lyme disease. Among the treatment recommendations, the guidelines recommend oral antibiotic therapy for most patients with Lyme disease.
The Lyme Disease Association (LDA) is providing you with this updated November 2, 2020, COVID-19 protocol developed by the Chief of Pulmonary and Critical Care Medicine, EVMS. The EVMS Medical continually updates this guideline as new information emerges, primarily to provide new information to physicians. This information is provided by LDA for informational purposes […]
Working Group Fight Continues/Horowitz Treatment Study/PA Tick Infection Rates/MyLymeData/COVID-19 & TBD/LymeX
Pat Smith in WG meeting on geographic boundaries preventing Lyme diagnosis: “I lived in the world of patients for 36 years, and I can tell you that they are not getting treated in those states because the government and other entities are telling them there is no disease. They are consistently not being diagnosed and treated, and you think this because there is a positive test they will get treated? No way. That doesn’t happen …
A study published in the journal Diagnostic Microbiology and Infectious Disease addresses the observed negative effects of the COVID-19 pandemic on the timely diagnosis of tick-borne infections (TBD) in three adult patients.
Co-Chair: “Persistent Lyme Religious Belief”/Lyme $$$ Amendments/ Tick Biowarfare Investigation Passes House/WNBA Denies Lyme-Covid Exemption/LDA’s New Spanish LymeR Primer/Lyme Vaccine Phase 2 Results/Asian Longhorned Tick Increases
Persistent Infection a Religious Belief? Working Group Co-Chair Says – YES! At the meeting itself, Working Group Co-Chair, Dr. David Walker, and Member Eugene Shapiro made and seconded many motions to remove material from the proposed draft report including the two sets of guidelines, shared decision making, access to care, Lyme treatment trials, and cost of Lyme disease.
The LDA is compiling a list of articles in the news & journals of possible interest regarding Covid-19 & Lyme disease. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies (Clinical Medicine – London) Melanie Dani, et al. Lyme Disease in the Era of COVID-19: A Delayed Diagnosis and Risk for Complications (Case Reports […]